Telix Pharmaceuticals Limited

TLX Health Care Biotechnology: Pharmaceutical Preparations

$9.54

▼ -14.5% Today

as of Oct 22, 16:52 ET

Last 30 days -19.02% Sep 14 → Oct 22

Open

$9.56

High

$9.61

Low

$9.43

Volume

$678,920

Avg Vol

$218,153

Mkt Cap

$3.9B

P/E (TTM)

—

Beta

—

52w High

$13.11

52w Low

$6.28

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 25 items

Oct 21 · 08:24 MT Newswires

Telix Pharmaceuticals Q3 Revenue Rises 19%

Oct 20 · 22:10 PR GlobeNewswire

Telix Reports Third Quarter 2026 Financial Performance

Oct 20 · 22:08 PR PR Newswire

Telix Reports Third Quarter 2026 Financial Performance

▸ Show all 25 press releases & news Free account →

TLX earnings at a glance

The share price of $9.54 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range

$6.28

$13

48% of range

Avg surprise (last 0)

—

Avg reaction (last 0)

—

Earnings trends

Implied volatility — last 90 days

No IV snapshots yet for TLX.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

CPRX

Catalyst Pharmaceuticals, Inc.

$3.9B $31.49

TNGX

Tango Therapeutics, Inc.

$3.7B $27.93+10.6%

INDV

Indivior Pharmaceuticals, Inc.

$4.3B $35.33+1.6%

IDYA

IDEAYA Biosciences, Inc.

$3.5B $36.12+2.1%

RCUS

Arcus Biosciences, Inc.

View on Nasdaq ↗